← Back to catalogue

SARS-CoV-2 & Influenza A+B Antigen Combo Rapid Test

EUDAMED

Class IVD General (EU MDR)

Ref COIF-522

by Sejoy Biomedical Co., Ltd.

Identity

Trade Name
SARS-CoV-2 & Influenza A+B Antigen Combo Rapid Test EUDAMED
Device Name
SARS-CoV-2 & Influenza A+B Antigen Combo Rapid Test EUDAMED
Model / Reference
COIF-522 EUDAMED

Identifiers

Primary DI / UDI-DI
06939663976800 EUDAMED
06939663978323 EUDAMED
Basic UDI-DI
B-06939663976800 EUDAMED
B-06939663978323 EUDAMED
EMDN Code
W0105040619 EUDAMED
W0105041101 CORONAVIRUS AG EUDAMED

Classification

Device Class
Class IVD General EUDAMED
Market of Registration
Germany EUDAMED
France EUDAMED

Clinical & Handling

Sterile

No

EUDAMED

Human Tissues

No

EUDAMED

Animal Tissues

No

EUDAMED

Microbial Substances

No

EUDAMED

Reagent

No

EUDAMED

Self Testing

No

EUDAMED

Near-Patient Testing

Yes

EUDAMED

Professional Testing

Yes

EUDAMED

Companion Diagnostics

No

EUDAMED

Surgical Instrument

No

EUDAMED

SARS-CoV-2 & Influenza A+B Antigen Combo Rapid Test by Sejoy Biomedical Co., Ltd. — Class IVD General — IVDD — listed in EUDAMED — regulatory data on deviCERTS

Authorization Coverage (European Union — 27 member states)

Regulatory Authorizations

European Union Active

CE/IVDD

Is this your device? Claim it to add documentation and request validation.

Manufacturer

EUDAMED SRN
CN-MF-000008447
Authorised Representative
Shanghai International Holding Corp. GmbH(Europe) DE-AR-000000001

Sources (2)

  • EUDAMED dd7f9d05-8be6-4029-9087-ee19e2153444 61 fields · synced Aug 3, 2026
  • EUDAMED 802e70ad-5d71-4aca-9190-23abd2191042 61 fields · synced May 17, 2026